Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00087022
Status:
COMPLETED
Last Update Posted:
2018-11-27
First Post:
2004-07-08
Brief Title:
Monoclonal Antibody Therapy Rencarex in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
Sponsor:
Heidelberg Pharma AG
Organization:
Heidelberg Pharma AG
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
None
Primary Completion Date:
2012-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-08
First Submit QC Date:
July 9 2004
Study First Post Date:
2004-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-09-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2014-01-28
Disp First Submit QC Date:
January 28 2014
Disp First Post Date:
2014-02-28
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-10-31
Last Update Post Date:
2018-11-27
Last Update Post Date Type:
ACTUAL